Mayinglong Pharmaceutical Group Co Ltd
Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. The company offers functional cosmetics, functional care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells medicinal packaging materials, cosmetics, and Chinese medicines; and offers… Read more
Mayinglong Pharmaceutical Group Co Ltd (600993) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.031x
Based on the latest financial reports, Mayinglong Pharmaceutical Group Co Ltd (600993) has a cash flow conversion efficiency ratio of 0.031x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.20 Million) by net assets (CN¥4.43 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Mayinglong Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Mayinglong Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Mayinglong Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mayinglong Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OEM-International AB Series B
LSE:0QTY
|
0.101x |
|
Byline Bancorp Inc
NYSE:BY
|
0.030x |
|
KEC International Limited
NSE:KEC
|
-0.163x |
|
NBCC (India) Limited
NSE:NBCC
|
-0.384x |
|
Shanghai Bailian Group Co Ltd A
SHG:600827
|
0.011x |
|
Srisawad Corporation Public Company Limited
BK:SAWAD-R
|
0.050x |
|
Fincantieri S.p.A
PINK:FNCNF
|
0.114x |
|
PageGroup plc
PINK:MPGPF
|
-0.043x |
Annual Cash Flow Conversion Efficiency for Mayinglong Pharmaceutical Group Co Ltd (2003–2024)
The table below shows the annual cash flow conversion efficiency of Mayinglong Pharmaceutical Group Co Ltd from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.20 Billion | CN¥497.61 Million | 0.118x | -24.12% |
| 2023-12-31 | CN¥3.87 Billion | CN¥604.07 Million | 0.156x | +65.24% |
| 2022-12-31 | CN¥3.62 Billion | CN¥341.85 Million | 0.094x | -47.57% |
| 2021-12-31 | CN¥3.31 Billion | CN¥597.17 Million | 0.180x | +87.62% |
| 2020-12-31 | CN¥2.95 Billion | CN¥282.99 Million | 0.096x | -48.52% |
| 2019-12-31 | CN¥2.63 Billion | CN¥491.58 Million | 0.187x | +42.35% |
| 2018-12-31 | CN¥2.35 Billion | CN¥308.24 Million | 0.131x | -16.43% |
| 2017-12-31 | CN¥2.27 Billion | CN¥356.17 Million | 0.157x | +32.02% |
| 2016-12-31 | CN¥2.02 Billion | CN¥239.60 Million | 0.119x | +22.57% |
| 2015-12-31 | CN¥1.89 Billion | CN¥182.85 Million | 0.097x | +47.44% |
| 2014-12-31 | CN¥1.70 Billion | CN¥111.67 Million | 0.066x | -20.76% |
| 2013-12-31 | CN¥1.57 Billion | CN¥129.94 Million | 0.083x | -29.74% |
| 2012-12-31 | CN¥1.43 Billion | CN¥169.25 Million | 0.118x | +106.81% |
| 2011-12-31 | CN¥1.32 Billion | CN¥75.37 Million | 0.057x | +663.58% |
| 2010-12-31 | CN¥1.13 Billion | CN¥-11.42 Million | -0.010x | -104.93% |
| 2009-12-31 | CN¥1.05 Billion | CN¥216.11 Million | 0.205x | +74.55% |
| 2008-12-31 | CN¥871.43 Million | CN¥102.59 Million | 0.118x | +1448.66% |
| 2007-12-31 | CN¥853.12 Million | CN¥6.49 Million | 0.008x | -91.36% |
| 2006-12-31 | CN¥855.21 Million | CN¥75.27 Million | 0.088x | -10.15% |
| 2005-12-31 | CN¥596.55 Million | CN¥58.43 Million | 0.098x | -0.19% |
| 2004-12-31 | CN¥552.20 Million | CN¥54.19 Million | 0.098x | -66.37% |
| 2003-12-31 | CN¥231.35 Million | CN¥67.52 Million | 0.292x | -- |